Patents by Inventor Ryota HABA

Ryota HABA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOUBLE-STRANDED RNA THAT INHIBITS PRODUCTION OF HEPATITIS B VIRUS PROTEIN AND PHARMACEUTICAL COMPOSITION
    Publication number: 20230340483
    Abstract: An object of the present invention is to provide a double-stranded RNA that is useful as a novel anti-hepatitis B virus agent, and a pharmaceutical composition containing the above-described double-stranded RNA. According to the present invention, there is provided a double-stranded RNA that inhibits the production of a hepatitis B virus protein and that inhibits the expression of YTHDC1.
    Type: Application
    Filed: March 29, 2023
    Publication date: October 26, 2023
    Applicant: FUJIFILM Corporation
    Inventors: Ryota HABA, Mayumi Ueda
  • PHARMACEUTICAL COMPOSITION THAT INHIBITS PRODUCTION OF HEPATITIS B VIRUS PROTEIN AND SCREENING METHOD
    Publication number: 20220042020
    Abstract: An object of the present invention is to provide a pharmaceutical composition useful as a novel anti-hepatitis B virus agent and a screening method. According to the present invention, there is provided a pharmaceutical composition that inhibits a production of a hepatitis B virus protein, in which the pharmaceutical composition inhibits an expression or a function of an RNA-binding protein that binds to at least one sequence selected from a hepatitis B virus RNA sequence corresponding to an enhancer I region sequence on a hepatitis B virus genome DNA or a hepatitis B virus RNA sequence corresponding to an enhancer II region sequence on the hepatitis B virus genome DNA.
    Type: Application
    Filed: September 23, 2021
    Publication date: February 10, 2022
    Applicants: FUJIFILM Corporation, PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY
    Inventors: Yasuhito TANAKA, Ryota HABA, Kazuki SHIMANE, Takaki KAWANO
  • PHARMACEUTICAL COMPOSITION THAT INHIBITS PRODUCTION OF HEPATITIS B VIRUS PROTEIN, PHARMACEUTICAL COMPOSITION FOR TREATING HEPATITIS B, AND SCREENING METHOD
    Publication number: 20220000903
    Abstract: An object of the present invention is to provide a pharmaceutical composition useful as a novel anti-hepatitis B virus agent and a screening method. According to the present invention, there is provided a pharmaceutical composition that inhibits the production of a hepatitis B virus protein, in which the pharmaceutical composition inhibits the expression or the function of a protein belonging to the YTHDC family.
    Type: Application
    Filed: September 23, 2021
    Publication date: January 6, 2022
    Applicant: FUJIFILM Corporation
    Inventors: Ryota HABA, Kazuki SHIMANE, Nozomi YAMASHITA